Mara Campioni

1.3k total citations
18 papers, 872 citations indexed

About

Mara Campioni is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mara Campioni has authored 18 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mara Campioni's work include Cerebrovascular and genetic disorders (7 papers), Ubiquitin and proteasome pathways (3 papers) and Uterine Myomas and Treatments (2 papers). Mara Campioni is often cited by papers focused on Cerebrovascular and genetic disorders (7 papers), Ubiquitin and proteasome pathways (3 papers) and Uterine Myomas and Treatments (2 papers). Mara Campioni collaborates with scholars based in Italy, United States and Germany. Mara Campioni's co-authors include Alfonso Baldi, Pietro G. Signorile, Antonio De Luca, Jeremy Chien, Viji Shridhar, Maria De Falco, Enrico P. Spugnini, Marco G. Paggi, Feliciano Baldi and Daniele Santini and has published in prestigious journals such as Journal of the American College of Cardiology, Clinical Cancer Research and Journal of Histochemistry & Cytochemistry.

In The Last Decade

Mara Campioni

18 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mara Campioni Italy 15 346 263 142 129 118 18 872
Quancai Cui China 20 411 1.2× 61 0.2× 200 1.4× 161 1.2× 73 0.6× 61 1.0k
Anna F. Lee Canada 16 433 1.3× 70 0.3× 116 0.8× 162 1.3× 144 1.2× 44 1.1k
Toshihide Matsumoto Japan 19 476 1.4× 46 0.2× 75 0.5× 119 0.9× 145 1.2× 58 973
Shinji Itoyama Japan 20 353 1.0× 148 0.6× 27 0.2× 41 0.3× 88 0.7× 64 1.3k
Esther S.Y. Wong Hong Kong 15 749 2.2× 23 0.1× 58 0.4× 89 0.7× 68 0.6× 20 1.0k
Robert Bayer United States 17 131 0.4× 88 0.3× 22 0.2× 80 0.6× 121 1.0× 23 754
Nives Pećina‐Šlaus Croatia 18 810 2.3× 118 0.4× 18 0.1× 26 0.2× 66 0.6× 56 1.4k
Piere Rogalla Germany 14 374 1.1× 17 0.1× 91 0.6× 73 0.6× 105 0.9× 29 859
Iain J. Brogan United Kingdom 9 460 1.3× 23 0.1× 78 0.5× 52 0.4× 192 1.6× 11 955
Elisabeth Steichen‐Gersdorf Austria 15 319 0.9× 246 0.9× 9 0.1× 41 0.3× 45 0.4× 27 793

Countries citing papers authored by Mara Campioni

Since Specialization
Citations

This map shows the geographic impact of Mara Campioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara Campioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara Campioni more than expected).

Fields of papers citing papers by Mara Campioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mara Campioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara Campioni. The network helps show where Mara Campioni may publish in the future.

Co-authorship network of co-authors of Mara Campioni

This figure shows the co-authorship network connecting the top 25 collaborators of Mara Campioni. A scholar is included among the top collaborators of Mara Campioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mara Campioni. Mara Campioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Severino, Anna, Mara Campioni, Davide Flego, et al.. (2017). Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4+T-lymphocytes in acute coronary syndromes. Oncotarget. 8(11). 17529–17550. 10 indexed citations
2.
Schmidt, Nina, Vanda Lux, Christian Johannes, et al.. (2016). Epigenetic silencing of serine protease HTRA1 drives polyploidy. BMC Cancer. 16(1). 399–399. 21 indexed citations
3.
Pieroni, Maurizio, Maria De Santis, Gaetano Zizzo, et al.. (2013). Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression. Seminars in Arthritis and Rheumatism. 43(4). 526–535. 109 indexed citations
4.
Baldi, Alfonso, Antonio De Luca, Vincenzo Esposito, et al.. (2011). Tumor Suppressors and Cell-Cycle Proteins in Lung Cancer. Pathology Research International. 2011. 1–12. 41 indexed citations
5.
Smaldone, Costantino, Maurizio Pieroni, Maria De Santis, et al.. (2010). BIOPSY-PROVEN ACTIVE MYOCARDITIS IN SYSTEMIC SCLEROSIS PATIENTS WITH RECENT-ONSET CARDIAC INVOLVEMENT. Journal of the American College of Cardiology. 55(10). A35.E340–A35.E340. 1 indexed citations
6.
Campioni, Mara, Anna Severino, Lucrezia Manente, et al.. (2010). The Serine Protease HtrA1 Specifically Interacts and Degrades the Tuberous Sclerosis Complex 2 Protein. Molecular Cancer Research. 8(9). 1248–1260. 40 indexed citations
7.
Chien, Jeremy, Mara Campioni, Viji Shridhar, & Alfonso Baldi. (2009). HtrA Serine Proteases as Potential Therapeutic Targets in Cancer. Current Cancer Drug Targets. 9(4). 451–468. 112 indexed citations
8.
Signorile, Pietro G., Mara Campioni, Bruno Vincenzi, Alfredo D’Avino, & Alfonso Baldi. (2009). Rectovaginal septum endometriosis: an immunohistochemical analysis of 62 cases.. PubMed. 23(3). 459–64. 30 indexed citations
9.
Baldi, Alfonso, Mara Campioni, & Pietro G. Signorile. (2008). Endometriosis: Pathogenesis, diagnosis, therapy and association with cancer (Review). Oncology Reports. 19(4). 843–6. 101 indexed citations
10.
Campioni, Mara, Vincenzo Ambrogi, Eugenio Pompeo, et al.. (2008). Identification of genes down-regulated during lung cancer progression: A cDNA array study. Journal of Experimental & Clinical Cancer Research. 27(1). 38–38. 28 indexed citations
11.
Baldi, Alfonso, Marcella Mottolese, Bruno Vincenzi, et al.. (2008). The Serine Protease HtrA1 is a Novel Prognostic Factor for Human Mesothelioma. Pharmacogenomics. 9(8). 1069–1077. 46 indexed citations
12.
Esposito, Vincenzo, Mara Campioni, Antonio De Luca, et al.. (2006). Analysis of HtrA1 serine protease expression in human lung cancer.. PubMed. 26(5A). 3455–9. 46 indexed citations
13.
Addeo, Raffaele, Michele Caraglia, Alfonso Baldi, et al.. (2005). Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia. Cancer Biology & Therapy. 4(1). 39–45. 31 indexed citations
14.
Campioni, Mara, Daniele Santini, Giuseppe Tonini, et al.. (2005). Role of Apaf‐1, a key regulator of apoptosis, in melanoma progression and chemoresistance. Experimental Dermatology. 14(11). 811–818. 50 indexed citations
15.
Baldi, Alfonso, Vincenzo Ambrogi, Davide Mineo, et al.. (2005). Analysis of Cell Cycle Regulator Proteins in Encapsulated Thymomas. Clinical Cancer Research. 11(14). 5078–5083. 13 indexed citations
16.
Luca, Antonio De, Maria De Falco, Luca De Luca, et al.. (2004). Pattern of Expression of HtrA1 During Mouse Development. Journal of Histochemistry & Cytochemistry. 52(12). 1609–1617. 34 indexed citations
17.
Luca, Antonio De, Maria De Falco, Valentina Fedele, et al.. (2004). The Serine Protease HtrA1 Is Upregulated in the Human Placenta during Pregnancy. Journal of Histochemistry & Cytochemistry. 52(7). 885–892. 53 indexed citations
18.
Luca, Antonio De, Maria De Falco, Anna Severino, et al.. (2003). Distribution of the Serine Protease HtrA1 in Normal Human Tissues. Journal of Histochemistry & Cytochemistry. 51(10). 1279–1284. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quancai Cui Breakdown of academic impact, for papers by Anna F. Lee Breakdown of academic impact, for papers by Toshihide Matsumoto Breakdown of academic impact, for papers by Shinji Itoyama Breakdown of academic impact, for papers by Esther S.Y. Wong Breakdown of academic impact, for papers by Robert Bayer Breakdown of academic impact, for papers by Nives Pećina‐Šlaus Breakdown of academic impact, for papers by Piere Rogalla Breakdown of academic impact, for papers by Iain J. Brogan Breakdown of academic impact, for papers by Elisabeth Steichen‐Gersdorf
Rankless by CCL
2026